Poll Shows 11% of Patients Did Not Plan on Getting 2024-2025 Respiratory Vaccination
Approximately 66% of patients received a COVID-19 vaccine in the fall of 2024 and only 26% received a respiratory syncytial virus vaccine.
Approximately 66% of patients received a COVID-19 vaccine in the fall of 2024 and only 26% received a respiratory syncytial virus vaccine.
An open access peer-reviewed journal from BMJ Group, publishing original research, review articles, and opinion pieces in the fields of digital health and artificial intelligence.
Pharmacists can have informed discussions with patients about the importance of adherence to tuberculosis (TB) treatment regimens, especially for patients with active TB.
This discussion highlights the importance of recognizing that everyone can engage in leading within their roles, while also addressing the crucial skills of followership and…
Interstitial cystitis/bladder pain (IC/BP) syndrome is a complex chronic condition that can be challenging to manage even with combinations of
Background Migraine is a common primary headache disorder, less frequently affecting men than women, and often regarded as predominantly a “women’s disease.” Despite this, migraine…
bioRxiv – the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution
One third of patients undergoing transcatheter aortic-valve implantation (TAVI) have an indication for oral anticoagulation owing to concomitant diseases. Interruption of oral anticoagulation durin…
For decades after the identification of mpox in humans in the Democratic Republic of Congo (DRC) in 1970, the disease was largely confined to the…
Psychologist Grace Tworek explains how to maximize the best traits of being a Type A personality while managing any negatives.
Endocrine therapy in combination with CDK4/6 inhibitors improves patients’ outcomes, but many still become treatment resistant.